25th Apr 2012 18:23
Barclays kicks off the banking results season on Thursday, but it will have plenty of competition for headline space from other heavyweights reporting on the same day, including pharmaceuticals giants Astra and Shire, plus Anglo-Dutch titans Royal Dutch Shell and Unilever. The results statement fro
Read more25th Apr 2012 11:54
- Footsie gains despite GDP data - Draghi continues to see downside risks - ARM rises on Apple earnings, broker upgrades After a strong start, the FTSE 100 index pared gains in mid-morning trade following some gloomy economic data that showed that the UK fell back into a 'technical' recession in th
Read more25th Apr 2012 08:16
- Q1 GDP expected to be flat - ARM up on upgrades, Apple earnings - Ex-div stocks lead the downside Stocks rose moderately in early trade on Wednesday as the Footsie still attempts to recover from Monday's steep sell-off. The release of first-quarter gross domestic product (GDP) figures for the UK
Read more24th Apr 2012 16:43
- Global markets rebound after yesterday's losses - Man Group jumps as UBS speculates over M&A - Shell makes 220p-a-share offer for Cove London's FTSE 100 index clawed its way back above the 5,700 level on Tuesday afternoon after a broadly stronger start on Wall Street. Europe's major benchmarks we
Read more24th Apr 2012 11:42
- Footsie corrects after sell-off - Man Group jumps as UBS speculates over M&A - Shell makes 220p-a-share offer for Cove UK stocks were making moderate gains by Tuesday lunchtime, rebounding after heavy losses the day before. US stock futures were pointing to a positive start on Wall Street ahead
Read more24th Apr 2012 09:27
ARM Holdings: Nomura maintains neutral rating and 600p target. Associated British Foods: Nomura keeps buy stance and 1,325p target; Jefferies mains hold recommendation and 1,155p target. Barclays: Investec maintains buy rating and 240p target. BBA Aviation: Jefferies keeps buy rating and 250p tar
Read more24th Apr 2012 08:40
- Footsie rebounds after Monday's steep losses - Shell makes 220p-a-share offer for Cove - Capita drops after proposing placing The FTSE 100 was clawing its way back slowly on Tuesday morning, following yesterday's steep sell-off which saw London's benchmark lose nearly two per cent of its value on
Read more23rd Apr 2012 11:30
Nomura has retained its neutral stance and 268p target price for UK lender Barclays ahead of its first-quarter statement due on Thursday April 26th. Despite its cautious view, Nomura does say that it prefers Barclays to its Eurozone peers, "given the headwinds faced by continental European economie
Read more23rd Apr 2012 11:01
Nomura has retained its neutral stance and 268p target price for UK lender Barclays ahead of its first-quarter statement due on Thursday April 26th. Despite its cautious view, Nomura does say that it prefers Barclays to its Eurozone peers, "given the headwinds faced by continental European economie
Read more23rd Apr 2012 08:56
ARM Holdings: JP Morgan Cazenove upgrades from underweight to neutral, target lifted from 400p to 540p. AstraZeneca: Barclays Capital upgrades from underweight to equal weight, target upped from 3,200p to 3,250p. Aviva: Goldman Sachs upgrades from neutral to buy. Barclays: Nomura reiterates neutr
Read more23rd Apr 2012 07:02
The Dutch prime minister will on Monday launch a bid to salvage his austerity budget amid political chaos that could cost the country its AAA credit rating and plunge Europe's debt rescue plans into disarray. Mark Rutte, who is a key ally of Germany and the Eurozone's "hardliners" on financial disci
Read more20th Apr 2012 10:57
Barclays kicks off the banking results season on Thursday, while the pharmaceuticals giants are also putting the finishing touches to their trading statements, with Glaxo, Astra and Shire all set to give first quarter updates. Anglo-Dutch Footsie heavyweights Royal Dutch Shell and Unilever will be
Read more20th Apr 2012 07:00
The determination to find new blockbuster drugs has encouraged GlaxoSmithKline to bid $2.6 billion for a company that it admits has uncertain prospects. GSK has offered to buy its long-term partner Human Genome Sciences for $13 a share, an 81 per cent premium to the previous day's price. The compani
Read more19th Apr 2012 16:32
- Stocks wobble after US data, French rumours - Spanish auction strong - Cable and Wireless Worldwide extends offer deadline After a solid start, London's blue chip index finished flat on Thursday as weaker-than-expected economic data from the US dampened sentiment late on. US stocks started cauti
Read more19th Apr 2012 14:01
In an effort to stave off further banker-bashing from politicians and the press, Barclays Chief Executive Bob Diamond and Finance Director Chris Lucas are to link half of their 2011 bonuses to the bank's future returns performance. Diamond and Lucas - awarded all-share bonuses in respect of their 2
Read more